GOVERNING, PROTECTING, AND REGULATING THE FUTURE OF GENOME EDITING : the significance of elspi perspectives

This book illustrates and demonstrates an array of challenges and opportunities that human genome editing offers. It provides arguments and proposals for transformative regulatory interventions as a way to promote technology development while protecting fundamental rights. Contents Acknowledgements Introduction: The Significance of ELSIP Perspectives in Governing, Protecting, and Regulating the Future of Genome Editing Part 1 A Roadmap of ELSIP Perspectives Genome Editing: Learning from Its Past and Envisioning Its Future Transformation of Medical Care through Gene Therapy and Human Rights to Life and Health – Balancing Risks and Benefits Somatic Genome Editing with the Use of AI: Big Promises but Doubled Legal Issues Addressing Cognitive Vulnerabilities through Genome and Epigenome Editing: Techno-Legal Adaptations for Persons with Intellectual Disabilities Regulating Heritable Human Genome Editing: Drawing the Line between Legitimate and Controversial Use The European Court of Human Rights and the Emergence of Human Germline Genome Editing – ‘The Right to Life’ and ‘the Right to (Artificial) Procreation’ The Object-Based and Process-Based Regulation of Genome Editing Part 2 Bringing Genome Editing to the Market and Making It Available to Patients A Room with a View (and with a Gene Therapy Drug): Gene Therapy Medicinal Products and Genetic Tourism in Europe What Would It Take to Enable Germline Editing in Europe for Medical Purposes? Genetics and Justice, Non-Ideal Theory and the Role of Patents: The Case of CRISPR-Cas9 Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law The Application of EU Competition Law to the Exploitation of Human Genome Editing Technology Index of Subjects Index of Legal Sources Index of Judicial Cases "This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law. In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society"-- Provided by publisher